NCT05904236 2025-04-08
ICVB-1042
IconOVir Bio
Phase 1 Terminated
Clinical Trials
6 trialsNCT03250299 2024-06-24
Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Basilea Pharmaceutica
Phase 1 Terminated
NCT00415246 2019-11-22
Study to Evaluate a Subcutaneous Four Months Sustained-release Formulation of Triptorelin in Patients With Prostate Cancer
Ipsen
Phase 3 Terminated
NCT01892293 2019-01-10
CT Antigen TCR-Engineered T Cells for Myeloma
Adaptimmune
Phase 1/2 Terminated
NCT01357863 2018-09-14
(TYCO1)
GlaxoSmithKline
Terminated
NCT00312442 2010-06-02
Phase II/III Study of WST09 in Prostate Cancer After Radiation Therapy
STEBA France
Phase 2/3 Terminated